The University of Iowa Research Foundation (UIRF) recently optioned technology for regeneration of damaged cartilage to CartilaJoint GenTech, LLC (CartilaJoint).
News
In a finding that could lead to better treatment of smoking-related lung diseases, a group of scientists from institutions across the country – including the University of Iowa – is reporting that about half of current or former smokers have respiratory symptoms similar to COPD and an increased risk for exacerbations or “flare ups” of their symptoms despite normal lung function and a lack of COPD diagnosis.
A new study suggests there may be an overlap between rare genetic variations linked to bipolar disorder (BD) and those implicated in schizophrenia and autism.
The University of Iowa Roy J. and Lucille A. Carver College of Medicine Commencement for the Class of 2016 will be held Friday, May 13, at 6:30 p.m. at the Coralville Marriott Hotel and Conference Center, Exhibit Hall.
Children’s Miracle Network has awarded Joseph W. Turek, MD, PhD, a $50,000 research grant. The grant application, entitled “Multi Level Interactions between CaMKII and TRPV 1 Contribute to Aortic Aneurysm Progression Marfan Syndrome,” was approved for funding through June 2017.
Frederick Domann, PhD, professor in the UI Carver College of Medicine, received a Distinguished Scientist Award from the Society for Experimental Biology and Medicine (SEBM) at the organization's annual meeting April 2–6 in San Diego.
Ryan Boudreau, PhD, UI assistant professor of internal medicine, has received a three-year, $438,657 Young Investigator award from the Roy J. Carver Charitable Trust to investigate regulatory mechanisms that control when and where proteins are made within heart cells.
The Carver College of Medicine’s 2015-2016 Distinguished Biomedical Scholars Lecture Series continues Thursday, May 5, with a talk by Howard Hughes Medical Institute Investigator Angelika Amon, PhD.
A new study shows the death of newborn brain cells may be linked to a genetic risk factor for five major psychiatric diseases, and at the same time shows a compound currently being developed for use in humans may have therapeutic value for these diseases by preventing the cells from dying.
The Ophthalmologist magazine recently named Edwin Stone, MD, PhD, to the 2016 Power List, a list of the top 100 most influential people in the world of ophthalmology.